AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)
| CAPS Rating |
|
|---|---|
| Open | $16.09 |
| Previous Close | $16.22 |
| Daily Range | $15.80 - $16.31 |
| 52-Week Range | $12.65 - $19.62 |
| Market Cap | $335.79M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 69,411 |
| Average Daily Volume | 0 |
How do you think AMAG will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AMAG Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AMAG News and Commentary
- Allos Therapeutics Cut to Neutral - Analyst Blog – NASDAQ
- AMAG Q4 Sales Set to Disappoint - Analyst Blog – NASDAQ
- AMAG's Feraheme Gets Canada Nod - Analyst Blog – NASDAQ
- Allos Continues to Outperform - Analyst Blog – NASDAQ
- 2-Star Stocks Poised to Plunge: AMAG Pharmaceuticals? – The Motley Fool
- AMAG Hires Financial Advisor - Analyst Blog – NASDAQ
- Mid-Day Update: Stocks Pare Some Early Losses; Unemployment Claims Lift Sentiment – NASDAQ
- Stocks Rally on European Debt Summit Optimism; December Crude Surges Over 2% – NASDAQ
- Mid-Day Update: Stocks Surge, Indexes Top 1% on Europe Debt Optimism, Earnings – NASDAQ
- Why Did My Stock Just Die? – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- 2nd UPDATE: AMAG Pharma Gets Offer From Fund Opposing Allos Deal – SmartMoney
- Hedge Fund Offers $378 Million for Amag in Unsolicited Bid – Minyanville
- AMAG-Allos, a Match Made in Necessity – The Motley Fool
- The 10 Most-Watched Diagnostic Substances Stocks – The Motley Fool
- Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment – NASDAQ
- Value Ideas: Insiders Think These Cash-Rich Small-Cap Stocks Are Undervalued – The Motley Fool
- AMAG Pharmaceuticals Posts Bigger Loss Than Expected – SeekingAlpha
- Top 13 Small-Cap Stocks Releasing Earnings Next Week, Backed by Insider Buying – SeekingAlpha
- What Shorts Might Be Watching at Rockwell Medical Technologies – The Motley Fool

RSS Headlines
Fool UK